Figure 5.

A, Experimental scheme for doxorubicin (DOX) and aspirin treatments. C57BL/6 mice were treated four times, once a week, from 2 wk of age with doxorubicin. One month later, the mice were fed drinking water with or without aspirin (0.02 g/100 mL) for 8 wk. B, Body weight gain and (C) white blood cell counts in PBS, aspirin, DOX, and DOX/aspirin‐treated male mice (n = 5). D, A representative photo of epididymal fat in PBS, aspirin, DOX, and DOX/aspirin‐treated male mice. E, Epididymal fat weight normalized to body weight (n = 4, *P < .05). Results expressed as means ± SEM